Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Motexafin gadolinium may increase the effectiveness of doxorubicin
by making tumor cells more sensitive to the drug.
PURPOSE: Phase I trial to study the effectiveness of combining motexafin gadolinium with
doxorubicin in treating patients who have recurrent or metastatic cancer.